CHOP Chief of Oncology Talks about the Promise of Car T-Cell Therapy in Cancer
Published on in CHOP News
Published on in CHOP News
Stephen P. Hunger, MD, Chief of the Division of Oncology at CHOP talks about the evolution and promise of CAR T-cell therapies in the treatment of refractory acute lymphoblastic leukemia (ALL), and opportunities to explore using the breakthrough therapy at earlier stages of the disease.